Author

Hans‐Ulrich Gremlich

Observed names: Dr. Hans-Ulrich Gremlich, Hans-Ulrich Gremlich

Observed institutions: Novartis (Switzerland), Merck KGaA, Darmstadt (Germany), Universidade Federal de Pernambuco, ETH Zurich, Sandoz Group AG (Switzerland), Novartis Institutes for BioMedical Research, Institute of Molecular Biology and Biophysics, Universidade Federal do Amazonas

OpenAlex ID: A5111863994

Works count: 40

Citation count: 1,658

H-index: 14

I10-index: 16